EBV-associated diseases have been the focus of the group's scientific work for many years. In clinical and preclinical studies, the group investigate the causes of protracted and severe courses of glandular fever. They are also developing new laboratory tests, looking for starting points for immunotherapy of EBV-associated diseases and developing an EBV vaccine. In addition, the group is involved in various projects in the research of COVID-19 and Long COVID. The focus of health services research is on ME/CFS projects.
(Description adapted from working group website: see link above)